Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL216256 | 0.88 | PTGS2 (0.62) | PTGS2PTGS1 | |
| SCHEMBL6091941 | 0.88 | PTGS2 (0.62) | PTGS2PTGS1 | |
| SCHEMBL5645790 | 0.83 | PTGS2 (0.55) | PTGS2PTGS1 | |
| SCHEMBL6093834 | 0.78 | PTGS2 (0.80) | PTGS2PTGS1 | |
| SCHEMBL6092626 | 0.78 | PTGS2 (0.80) | PTGS2PTGS1 | |
| SCHEMBL6092661 | 0.78 | PTGS2 (0.62) | PTGS2PTGS1 | |
| SCHEMBL6092668 | 0.78 | PTGS2 (0.62) | PTGS2PTGS1 | |
| SCHEMBL5648151 | 0.78 | PTGS2 (0.70) | PTGS2PTGS1 | |
| SCHEMBL27918723 | 0.77 | PTGS2 (0.61) | PTGS2PTGS1 | |
| SCHEMBL5708992 | 0.76 | PTGS2 (0.67) | PTGS2PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1572186-A2 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF HERPES VIRUS INFECTIONS USING CYCLOOXYGENASE-2 SELECTIVE INHIBITORS OR CYCLOOXYGENASE-2 INHIBITORS IN COMBINATION WITH ANTIVIRAL AGENTS | Pharmacia Corporation (US) | 2005-09-14 | — | — | EP | disclosed |
| WO-2004056349-A2 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF HERPES VIRUS INFECTIONS USING CYCLOOXYGENASE-2 SELECTIVE INHIBITORS OR CYCLOOXYGENASE-2 INHIBITORS IN COMBINATION WITH ANTIVIRAL AGENTS | PHARMACIA CORPORATION (US) | 2004-07-08 | — | — | WO | disclosed |